Complete ELVN Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
ELVN Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$-104.75
-612.1%
Peer Median: 55.3x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.6x
P/S Ratio
$0.00
-100.0%
Peer Median: 5.1x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for ELVN's business model and current situation.
Multiple Comparison
| Multiple | ELVN Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -10.8x | 55.3x | 46.8x | -119.5% | Undervalued |
| EV/EBITDA | Infinityx | 45.6x | 25.4x | Infinity% | Overvalued |
| P/S Ratio | Infinityx | 5.1x | 6.4x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $1.08B | 0.0x | 67.8x | 5.1x | |
| $0.97B | 22.6x | 5.3x | 1.5x | |
| $0.93B | 55.3x | 50.3x | 11.3x | |
| $0.89B | 0.0x | 0.0x | 0.0x | |
| $1.00B | 0.0x | 0.0x | 0.0x | |
| $0.73B | 0.0x | 0.0x | 3.3x | |
| $0.85B | 0.0x | 0.0x | 77.4x | |
| $0.65B | 0.0x | 0.0x | 2.4x | |
| $729.91B | 62.5x | 45.6x | 14.9x |